Literature DB >> 27143281

Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives.

Roberto Diletti1, Didier Tchetche2, Emanuele Barbato3, Azeem Latib4,5, Bruno Farah2, Robert-Jan van Geuns6, Antonio Colombo4,5, Jean Fajadet2, Nicolas M van Mieghem6.   

Abstract

Bioresorbable vascular scaffolds have been recently introduced as a novel paradigm for coronary artery disease treatment allowing temporary vessel support and drug delivery without indefinite coronary caging, potentially reducing the long-term limitation of metallic stents. The scientific community has rapidly embraced this concept and bioresorbable devices have been introduced in clinical practice. However, despite the fact that bifurcation lesions represent a large and challenging subset in the field of interventional cardiology, this subgroup of lesions have been avoided in the initial experience with bioresorbable scaffolds and clear recommendations on methodological approaches are lacking. In the present report, we describe the various techniques for bifurcation treatment with bioresorbable scaffolds and the theoretical advantages and disadvantages of this technology in different scenarios, with a glimpse to challenging subsets and possible complications. Therefore, we aim to provide experience based insights and practical guidance for bioresorbable scaffold implantation in bifurcation lesions.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  bifurcations; bioresorbable vascular scaffolds; methodological approaches

Mesh:

Year:  2016        PMID: 27143281     DOI: 10.1002/ccd.26454

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  1 in total

1.  Acute Angiographic and Intermediate-Term Clinical Results of Patients with Non-Left Main Coronary Bifurcation Lesions Treated with BVS by Jailed Semi-Inflated Balloon Technique and Provisional Side-Branch Stenting Strategy.

Authors:  Chieh-Shou Su; Keng-Hao Chang; Chih-Hung Lai; Yu-Wei Chen; Tzu-Hsiang Lin; Hung-Chih Pan; Tsun-Jui Liu; Wen-Lieng Lee
Journal:  J Interv Cardiol       Date:  2019-10-03       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.